Target
tacrolimus
2 abstracts
Abstract
Myeloablative fractionated busulfan-based conditioning regimen in patients with AML and MDS: Results of a randomized clinical trial comparing 2 fractionation schedules.Org: University of Texas MD Anderson Cancer Center, Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan, Department of Stem Cell Transplantation & Cellular Therapy,
Abstract
The safety, tolerability and efficacy of LP-10 in subjects with refractory moderate to severe hemorrhagic cystitis: Phase 2a multicenter dose escalation clinical trial.Org: Lipella Pharmaceuticals, University of California San Francisco Department of Urology, Emory University School of Medicine, Baylor College of Medicine, Vanderbilt University Medical Center,